Table 3 Short-term treatment outcomes according to bridging interval
Bridging interval | P-value | |||||||
|---|---|---|---|---|---|---|---|---|
Total n (%) | Group 1 ≤2 weeks n (%) | Group 2 2–3 week n (%) | Group 3 >3 weeks n (%) | Overall | ≤2 weeks vs. 2–3 weeks | 2–3 weeks vs. >3 weeks | ≤2 weeks vs. >3 weeks | |
Number of patients | 148 | 47 | 43 | 58 | ||||
SEMS-related complication | 14 (9.5) | 7 (14.9) | 3 (7.0) | 4 (6.9) | 0.305 | 0.320 | 0.859 | 0.408 |
Perforation | 2 (1.4) | 2 (4.3) | 0 (0.0) | 0 (0.0) | 0.182 | 0.495 | NA | 0.198 |
Migration | 8 (5.4) | 5 (10.6) | 1 (2.3) | 2 (3.4) | 0.214 | 0.206 | 1.000 | 0.238 |
Pain | 1 (0.7) | 0 (0.0) | 1 (2.3) | 0 (0.0) | 0.291 | 0.478 | 0.426 | NA |
Bleeding | 1 (0.7) | 0 (0.0) | 1 (2.3) | 0 (0.0) | 0.291 | 0.478 | 0.426 | NA |
Fever | 2 (1.4) | 0 (0.0) | 0 (0.0) | 2 (3.4) | 0.207 | NA | 0.334 | 0.326 |
Operation related complications within 90 days | 58 (39.2) | 18 (38.3) | 18 (41.9) | 22 (37.9) | 0.932 | 0.830 | 0.837 | 1.000 |
Clavien–Dindo classification (n=58) | 0.904 | 1.000 | 1.000 | 0.673 | ||||
Grade 1–2 | 49 (84.5) | 16 (88.9) | 15 (83.3) | 18 (81.8) | ||||
Grade 3–5 | 9 (15.5) | 2 (11.1) | 3 (16.7) | 4 (18.2) | ||||
Post-resection hospital stays, median days (IQR days) | 8.0 (7.0–11.8) | 9.0 (7.0–13.0) | 8.0 (7.0–11.0) | 8.0 (7.0–10.0) | 0.159 | 0.210 | 0.652 | 0.059 |
90-day mortality | 2 (1.4) | 0 (0.0) | 0 (0.0) | 2 (3.4) | 0.334 | NA | 0.506 | 0.501 |
Interval from resection to adjuvant chemotherapy, median days (IQR days) (n=116) | 34.5 (30.0–41.0) | 32.0 (29.0–41.3) | 36.0 (31.0–41.0) | 34.0 (30.0–39.0) | 0.470 | 0.331 | 0.269 | 0.666 |